ERYPRO SAFE 40000 INJ

Name: ERYPRO SAFE 40000 INJ
Brand: SURYA SPECIALITY PHARMA
Price: 10890 INR
Availability: InStock

Price 10890 INR/ Number

Get a Price/Quote

MOQ : 1 Number

ERYPRO SAFE 40000 INJ Specification

Indication
Anemia, particularly in patients with chronic kidney disease or undergoing chemotherapy

Origin of Medicine
Biotechnology

Dosage Form
Injection

Salt Composition
Epoetin alfa 40000 IU (Recombinant human erythropoietin)

Pacakaging (Quantity Per Box)
1 vial per box

Drug Type
Allopathic

Ingredients
Recombinant human erythropoietin (rhEPO)

Physical Form
Liquid

Function
Stimulates erythropoiesis (red blood cell production)

Recommended For
Patients with anemia due to chronic kidney disease or chemotherapy

Dosage
40000 IU per vial

Dosage Guidelines
As directed by the physician

Suitable For
Adults

Quantity
1 vial

Storage Instructions
Store at 2°C to 8°C. Do not freeze.

Prescription Required
Yes

Therapeutic Class
Anti-anemic

Route of Administration
Subcutaneous or intravenous injection

Brand Name
Erypro Safe

Contraindications
Uncontrolled hypertension, sensitivity to albumin or mammalian cell-derived products

Side Effects
Hypertension, headache, arthralgia, injection site reactions

Appearance
Clear, colorless solution

Shelf Life
24 months from date of manufacturing

ERYPRO SAFE 40000 INJ About

BENEFITS OF ERYPRO SAFE INJECTION

In Treatment of Anemia due to chronic kidney disease

Erypro Safe 40000IU Injection is a man-made protein that helps your bone marrow to produce more red blood cells. It is used to treat anemia which is caused by kidney disease in adults and children who are on dialysis. Anemia is a condition where your body does not have enough red blood cells to carry oxygen around your body. This medicine helps reduce weakness and tiredness that you may be experiencing due to anemia. The injection is usually given by a doctor after a dialysis treatment.

How Erypro Safe Works

Erypro Safe 40000 INJ contains recombinant human erythropoietin, a biotechnologically produced protein that prompts the bone marrow to generate more red blood cells. This helps correct anemia, a condition often linked to chronic kidney disease or chemotherapy, by boosting the body's oxygen-carrying capacity.

Who Should Use Erypro Safe

Erypro Safe is recommended for adults diagnosed with anemia related to chronic kidney disease or following chemotherapy. The injection must be prescribed and administered following a physician's guidance, ensuring the dosage and frequency are tailored for each patient's unique needs and health status.

Proper Storage and Handling

To maintain the efficacy of Erypro Safe, store the vials in a refrigerator at 2C to 8C. Do not freeze the product, and always check the solution to ensure it remains clear and colorless before use. Follow all healthcare professional instructions for safe handling and administration.

FAQ's of ERYPRO SAFE 40000 INJ:

Q: How should Erypro Safe 40000 INJ be administered?

A: Erypro Safe 40000 INJ is intended for subcutaneous (under the skin) or intravenous (into a vein) injection. Administration should be performed by a healthcare professional or as directed by your physician to ensure proper dosing and technique.

Q: What are the recommended storage conditions for Erypro Safe?

A: Erypro Safe must be stored in a refrigerator at 2C to 8C. It should never be frozen. The solution should always be clear and colorless; do not use it if it appears cloudy or contains particles.

Q: When is Erypro Safe typically prescribed?

A: Doctors prescribe Erypro Safe to adult patients who have anemia due to chronic kidney disease or as a result of undergoing chemotherapy. The drug supports increased red blood cell production and thus helps manage symptoms of anemia.

Q: What are the key benefits of using Erypro Safe?

A: Erypro Safe boosts red blood cell production, helping improve energy levels and reduce fatigue associated with anemia. This can enhance overall quality of life for patients with chronic kidney disease or those receiving chemotherapy.

Q: Are there any contraindications or people who should not use Erypro Safe?

A: Erypro Safe should not be used by individuals with uncontrolled hypertension or those who are hypersensitive to albumin or mammalian cell-derived products. Always discuss your full medical history with your doctor before beginning treatment.

Q: What side effects may occur with Erypro Safe?

A: Possible side effects include hypertension, headache, joint pain (arthralgia), and reactions at the injection site. Inform your healthcare provider if you experience any of these or other unusual symptoms after administration.

Q: How is the appropriate dosage for Erypro Safe determined?

A: The dosage and frequency of administration for Erypro Safe are determined by your physician based on your individual medical condition, hemoglobin levels, and therapeutic response. Never self-adjust the dose without professional guidance.

Tell us about your requirement